SKYE Latest Press Releases

-- August 14, 2026 --

Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings Globe Newswire 9:33 AM

-- May 20, 2026 --

Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1 Globe Newswire 7:00 AM

-- May 12, 2026 --

UPDATE - Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update Globe Newswire 1:33 PM

-- May 11, 2026 --

Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update Globe Newswire 4:01 PM

-- April 22, 2026 --

Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm Globe Newswire 9:36 AM

-- April 7, 2026 --

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit Globe Newswire 7:00 AM

-- April 2, 2026 --

Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software